VIVANI MED.INC. NEW O.N. (F:U5P) — Market Cap & Net Worth
Market Cap & Net Worth: VIVANI MED.INC. NEW O.N. (U5P)
VIVANI MED.INC. NEW O.N. (F:U5P) has a market capitalization of $79.34 Million (€67.86 Million) as of June 20, 2026. Listed on the F stock exchange, this Germany-based company holds position #20194 globally and #1850 in its home market, demonstrating a 1.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VIVANI MED.INC. NEW O.N.'s stock price €0.92 by its total outstanding shares 86235104 (86.24 Million). Review VIVANI MED.INC. NEW O.N. debt and liabilities to assess the company's total debt and financial obligations.
VIVANI MED.INC. NEW O.N. Market Cap History: 2015 to 2026
VIVANI MED.INC. NEW O.N.'s market capitalization history from 2015 to 2026. Data shows change from $569.42 Million to $92.75 Million (-17.06% CAGR).
VIVANI MED.INC. NEW O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VIVANI MED.INC. NEW O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of U5P by Market Capitalization
Companies near VIVANI MED.INC. NEW O.N. in the global market cap rankings as of June 20, 2026.
Key companies related to VIVANI MED.INC. NEW O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
VIVANI MED.INC. NEW O.N. Historical Marketcap From 2015 to 2026
Between 2015 and today, VIVANI MED.INC. NEW O.N.'s market cap moved from $569.42 Million to $ 92.75 Million, with a yearly change of -17.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €92.75 Million | -5.15% |
| 2025 | €97.79 Million | -6.73% |
| 2024 | €104.85 Million | +13.04% |
| 2023 | €92.75 Million | +14.29% |
| 2022 | €81.16 Million | -45.24% |
| 2021 | €148.20 Million | -22.63% |
| 2020 | €191.55 Million | +192.31% |
| 2019 | €65.53 Million | -9.72% |
| 2018 | €72.59 Million | -57.87% |
| 2017 | €172.30 Million | -9.82% |
| 2016 | €191.05 Million | -66.45% |
| 2015 | €569.42 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of VIVANI MED.INC. NEW O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $79.34 Million USD |
| MoneyControl | $79.34 Million USD |
| MarketWatch | $79.34 Million USD |
| marketcap.company | $79.34 Million USD |
| Reuters | $79.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About VIVANI MED.INC. NEW O.N.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more